AMSilk GmbH

Biotechnology, Medical Technology, Nanotechnology, New Materials

Products/services: The AMSilk®-Technology enables the production of biopolymers such as spider silk on an industrial scale. These materials are unrivaled by most common synthetic materials. AMSilk addresses many applications and industry sectors with new materials enabling new products with previously unachievable features. Tailor-made materials using the AMSilk®-Technology enable new and superior products with previously unachievable features, spanning multiple industries and applications

    • Short facts
      • Research & Development
    • Year founded 2008
    • 25 Employees (site)
    • Turnover: not available
    AMSilk GmbH
    Am Klopferspitz 19
    82152 Planegg
    München / Upper Bavaria
    +49 89 5795393-0
    not available
    Language skills
    English, German
    Contact person
    Management, Research & development: Dr. Lin Römer (Mr.)
    Location Map
    Key to Bavaria Map
  • Core competencies

    AMSilk is the world's first industrial supplier of synthetic silk biopolymers produced by a patented biotechnological process

    Key sectors / sub-sectors
    • Biotechnology: Biomaterials
    • Biotechnology: Drug delivery
    • Biotechnology: Tissue engineering and regenerative medicine
    • Medical Technology: Implants, biomaterials, tissue engineering
    • Nanotechnology: Biocompatible materials and layers
    • Nanotechnology: Drug encapsulation, targeted drug delivery
    • New Materials: Fibers and textiles
    Certifications / awards

    not available

    Sales markets - target industries
    not available
    Sales markets - target countries
    not available
    Cooperation offers
    not available